Psilocybin for Cancer Patients with Comorbid Mental Health Conditions (2 CE)

$24.99
In stock
SKU
1155CE

This course is for: Psychologists, Counselors, Social Workers, and Nurses

Course By: Paula Lin, LMFT

Content By: Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology30(12), 1181–1197. doi: 10.1177/0269881116675513

Course Description:  Patients diagnosed with life-threatening forms of cancer may present with comorbid mental health conditions due to the psychological and emotional distress that is resultant from the respective underlying physical illness. The presence of mental health symptoms can effectively function as treatment barriers. A randomized, double-blind, longitudinal trial was developed and implemented to test the efficacy of psilocybin for psychological and emotional symptom mitigation in patients presenting with life-threatening cancer-types. Patients who received high doses of psilocybin evidenced a clinically significant decrease in depressed mood and anxiety up to 6 months post-treatment.

Learning Objectives:

  1. Learn about comorbid mental health conditions in patients with life-threatening cancer and the related impact on life-quality and treatment participation
  2. Review the methods of the randomized double-blind trial
  3. Understand the statistical outcomes of the study and the related treatment implications for this demographic

Course Outline:

  1. Read and understand the referenced article Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
  2. Review the Course Description and Learning Objectives
  3. Evaluate and understand the results of the randomized double-blind trial and how the application of these findings may impact mental health treatment for this demographic
  4. Complete the post-test using the information derived from the article
  5. Utilize the referenced article to identify answers to questions in the post-test and/or to understand the study limitations and suggested direction for future research endeavors

Approvals:

Association for Advanced Training in the Behavioral Sciences is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. Association for Advanced Training in the Behavioral Sciences maintains responsibility for this program and its contents.

Association for Advanced Training in the Behavioral Sciences has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5750. Programs that do not qualify for NBCC credit are clearly identified. Association for Advanced Training in the Behavioral Sciences is solely responsible for all aspects of the programs.

Association for Advanced Training in the Behavioral Sciences provider #1085, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org, through the Approved Continuing Education (ACE) program. Association for Advanced Training in the Behavioral Sciences maintains responsibility for the program. ASWB Approval Period: 06/19/2018 – 06/19/2021. Social workers should contact their regulatory board to determine course approval for continuing education credits.

Florida Board of Clinical Social Work, Marriage & Family Therapy and Mental Health Counseling - #50-11015

Florida Board of Psychology #50-5452

NYSED:

Social Workers: Association for the Advanced Training in the Behavioral Sciences is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0112.

Counselors: Association for the Advanced Training in the Behavioral Sciences is recognized by the New York State Education Department's State Board for Mental Health Counselors as an approved provider of continuing education for licensed counselors #MHC-0165.

Marriage Family Therapists: Association for the Advanced Training in the Behavioral Sciences is recognized by the New York State Education Department's State Board for Marriage Family Therapists as an approved provider of continuing education for licensed Marriage Family Therapists #MFT-0077.

The sponsor of this program has been approved to offer Continuing Education credit for Certified Addiction Specialists (CAS) in accordance with the American Academy of Health Care Providers in the Addictive Disorders. Approval No. 20-1420.

Continuing Education licensing requirements vary by jurisdiction, are not always well defined and may even supersede the rules of a national accreditation organization. We recommend you contact the applicable state licensing board or accrediting organization for the latest regulations and specific requirements of your state when considering our programs for Continuing Education credit.

Grievance/Refund Policy

AATBS is fully committed to conducting all activities in strict conformance with the major mental health approving boards. AATBS will comply with all legal and ethical responsibilities to be non-discriminatory in promotional activities, program content and in the treatment of program participants. The monitoring and assessment of compliance with these standards will be the responsibility of the Program Director in consultation with the members of the continuing education committee.

Customer satisfaction is important to us. If you are unsatisfied for any reason, please send your complaint or questions in writing to info@aatbs.com. You can view our refund policy here.

Accommodations for Disabilities

To request accommodation; please contact our office at 1-800-472-1931 or email info@aatbs.com.

 

Write a review
Write Your Own Review
You're reviewing:Psilocybin for Cancer Patients with Comorbid Mental Health Conditions (2 CE)
How do you rate this product?
0/5